Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company ...

Eli Lilly’s GIP/GLP-1 dual receptor agonist Mounjaro (tirzepatide) has demonstrated cardiovascular protection in a late-stage ...

Het Amerikaanse Eli Lilly is de fabrikant van tirzepatide. Semaglutide wordt geproduceerd door de Deense farmaceut Novo Nordisk. Aan beide middelen is wereldwijd een tekort, juist vanwege de werking ...

Eli Lilly ging donderdag 10 procent onderuit op de aandelenbeurzen in New York. De farmaceut deed afgelopen kwartaal opnieuw ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

The complaint alleges the Indianapolis-based drugmaker offered illegal incentives to influence Texas providers to prescribe ...

Eli Lilly's Q2 earnings soared, fueled by Mounjaro and Zepbound's impressive sales, leading to raised full-year guidance.

Eli Lilly stock falls 14% after new obesity drug underwhelms in clinical trial. Analysts maintain Buy rating, citing strong ...

Eli Lilly and Company is gearing up for its second quarter earnings report this Thursday, before the market opens. The ...